{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:18:33Z","timestamp":1794557913930,"version":"4.9.1"},"reference-count":39,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,1,15]]},"abstract":"<jats:p>The hemolytic uremic syndrome (HUS) is a triad of microangiopathic hemolytic anemia, thrombocytopenia, and renal impairment. Genetic studies demonstrate that heterozygous mutations of membrane cofactor protein (MCP;CD46) predispose to atypical HUS (aHUS), which is not associated with exposure to Shiga toxin (Stx). Among the initial 25 MCP mutations in patients with aHUS were 2, R69W and A304V, that were expressed normally and for which no dysfunction was found. The R69W mutation is in complement control protein module 2, while A304V is in the hydrophobic transmembrane domain. In addition to 3 patients with aHUS, the A304V mutation was identified in 1 patient each with fatal Stx-HUS, the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome, and glomerulonephritis with C3 deposits. A major goal was to assess if these putative mutations lead to defective complement regulation. Permanent cell lines expressing the mutated proteins were complement \u201cchallenged,\u201d and membrane control of C3 fragment deposition was monitored. Both the R69W and A304V MCP mutations were deficient in their ability to control the alternative pathway of complement activation on a cell surface, illustrating the importance of modeling transmembrane proteins in situ.<\/jats:p>","DOI":"10.1182\/blood-2007-04-084533","type":"journal-article","created":{"date-parts":[[2007,10,4]],"date-time":"2007-10-04T00:58:44Z","timestamp":1191459524000},"page":"624-632","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":127,"title":["Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome"],"prefix":"10.1182","volume":"111","author":[{"given":"Celia J.","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Fremeaux-Bacchi","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, Service d'Immunologie Biologique, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Kathryn","family":"Liszewski","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Pianetti","sequence":"additional","affiliation":[{"name":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Bergamo, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Noris","sequence":"additional","affiliation":[{"name":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Bergamo, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy H. J.","family":"Goodship","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111813310235500_B1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies.","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"key":"2019111813310235500_B2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome.","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"key":"2019111813310235500_B3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.","volume":"68","author":"Perez-Caballero","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2019111813310235500_B4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1086\/318203","article-title":"Factor H mutations in hemolytic uremic syndrome cluster in exons 18\u201320, a domain important for host cell recognition.","volume":"68","author":"Richards","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2019111813310235500_B5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","article-title":"The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.","volume":"12","author":"Caprioli","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2019111813310235500_B6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","article-title":"Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases.","volume":"15","author":"Dragon-Durey","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2019111813310235500_B7","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.","volume":"100","author":"Richards","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111813310235500_B8","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0140-6736(03)14742-3","article-title":"Familial haemolytic uraemic syndrome and an MCP mutation.","volume":"362","author":"Noris","year":"2003","journal-title":"Lancet"},{"key":"2019111813310235500_B9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2019111813310235500_B10","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH and IF mutations on clinical presentation, response to treatment, and outcome.","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"2019111813310235500_B11","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1681\/ASN.2005101051","article-title":"Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.","volume":"17","author":"Fremeaux-Bacchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2019111813310235500_B12","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome.","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J Med Genet"},{"key":"2019111813310235500_B13","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2005010103","article-title":"Mutations in complement factor I predispose to the development of atypical hemolytic uremic syndrome.","volume":"16","author":"Kavanagh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2019111813310235500_B14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molimm.2006.07.004","article-title":"Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.","volume":"44","author":"Richards","year":"2007","journal-title":"Mol Immunol"},{"key":"2019111813310235500_B15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1073\/pnas.82.3.859","article-title":"Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.","volume":"82","author":"Cole","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111813310235500_B16","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.175.6.1547","article-title":"Membrane cofactor protein (MCP;CD46) protects cells from complement-mediated attack by an intrinsic mechanism.","volume":"175","author":"Oglesby","year":"1992","journal-title":"J Exp Med"},{"key":"2019111813310235500_B17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1084\/jem.163.4.837","article-title":"Purification and characterization of a membrane protein (gp45\u201370) that is a cofactor for cleavage of C3b and C4b.","volume":"163","author":"Seya","year":"1986","journal-title":"J Exp Med"},{"key":"2019111813310235500_B18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj2640581","article-title":"Functional properties of membrane cofactor protein of complement.","volume":"264","author":"Seya","year":"1989","journal-title":"Biochem J"},{"key":"2019111813310235500_B19","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0161-5890(91)90029-J","article-title":"Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).","volume":"28","author":"Seya","year":"1991","journal-title":"Mol Immunol"},{"key":"2019111813310235500_B20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<815::AID-IMMU815>3.0.CO;2-8","article-title":"Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation.","volume":"29","author":"Devaux","year":"1999","journal-title":"Eur J Immunol"},{"key":"2019111813310235500_B21","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.4049\/jimmunol.168.12.6298","article-title":"Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.","volume":"168","author":"Barilla-LaBarca","year":"2002","journal-title":"J Immunol"},{"key":"2019111813310235500_B22","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.molimm.2006.08.024","article-title":"Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.","volume":"44","author":"Liszewski","year":"2007","journal-title":"Mol Immunol"},{"key":"2019111813310235500_B23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jmg.2006.045328","article-title":"Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.","volume":"44","author":"Servais","year":"2007","journal-title":"J Med Genet"},{"key":"2019111813310235500_B24","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/hmg\/ddi099","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2019111813310235500_B25","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.4049\/jimmunol.161.7.3711","article-title":"Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function.","volume":"161","author":"Liszewski","year":"1998","journal-title":"J Immunol"},{"key":"2019111813310235500_B26","doi-asserted-by":"crossref","first-page":"37692","DOI":"10.1074\/jbc.M004650200","article-title":"Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46).","volume":"275","author":"Liszewski","year":"2000","journal-title":"J Biol Chem"},{"key":"2019111813310235500_B27","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.156.11.4415","article-title":"Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement.","volume":"156","author":"Liszewski","year":"1996","journal-title":"J Immunol"},{"key":"2019111813310235500_B28","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.molimm.2005.11.008","article-title":"Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.","volume":"43","author":"Esparza-Gordillo","year":"2006","journal-title":"Mol Immunol"},{"key":"2019111813310235500_B29","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1093\/emboj\/18.11.2911","article-title":"Crystal structure of two CD46 domains reveals an extended measles virus-binding surface.","volume":"18","author":"Casasnovas","year":"1999","journal-title":"EMBO J"},{"key":"2019111813310235500_B30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nsmb1190","article-title":"Adenovirus type 11 binding alters the conformation of its receptor CD46.","volume":"14","author":"Persson","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"2019111813310235500_B31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/adc.85.2.125","article-title":"Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features.","volume":"85","author":"Elliott","year":"2001","journal-title":"Arch Dis Child"},{"key":"2019111813310235500_B32","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","article-title":"Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease.","volume":"12","author":"Caprioli","year":"2003","journal-title":"Hum Mol Genet"},{"key":"2019111813310235500_B33","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.grf.0000160309.73197.35","article-title":"Controversies with the diagnosis and management of HELLP syndrome.","volume":"48","author":"O'Brien","year":"2005","journal-title":"Clin Obstet Gynecol"},{"key":"2019111813310235500_B34","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.4049\/jimmunol.165.7.3999","article-title":"Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.","volume":"165","author":"Brodbeck","year":"2000","journal-title":"J Immunol"},{"key":"2019111813310235500_B35","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/1521-4141(200003)30:3<900::AID-IMMU900>3.0.CO;2-X","article-title":"CD46 (membrane cofactor protein) associates with multiple beta 1 integrins and tetraspans.","volume":"30","author":"Lozahic","year":"2000","journal-title":"Eur J Immunol"},{"key":"2019111813310235500_B36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0161-5890(01)00100-6","article-title":"Molecular assembly of CD46 with CD9, alpha 3-beta 1 integrin and protein tyrosine phosphatase SHP-1 in human macrophages through differentiation by GM-CSF.","volume":"38","author":"Kurita-Taniguchi","year":"2002","journal-title":"Mol Immunol"},{"key":"2019111813310235500_B37","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1167\/iovs.02-0813","article-title":"Novel role for a complement regulatory protein (CD46) in retinal pigment epithelial adhesion.","volume":"44","author":"McLaughlin","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2019111813310235500_B38","doi-asserted-by":"crossref","first-page":"46927","DOI":"10.1074\/jbc.M308261200","article-title":"Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis.","volume":"278","author":"Crimeen-Irwin","year":"2003","journal-title":"J Biol Chem"},{"key":"2019111813310235500_B39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri1994","article-title":"T-cell regulation: with complements from innate immunity.","volume":"7","author":"Kemper","year":"2007","journal-title":"Nat Rev Immunol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/2\/624\/1220205\/zh800208000624.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/2\/624\/1220205\/zh800208000624.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T09:38:45Z","timestamp":1684057125000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/111\/2\/624\/103681\/Membrane-cofactor-protein-mutations-in-atypical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,15]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,1,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-04-084533","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,15]]}}}